This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of "ABRYSVO VIAL WITH DILUENT SYRGS" medical supplies. The order has a firm fixed price of $30,357.37 and a completion date of September 12, 2024. Amerisourcebergen, through its Corporate Office Division, is a key vendor for the DLA, holding an Indefinite Delivery Contract (IDC) valued up to $999,999,999...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, under a firm fixed-price contract with a ceiling value of $34,628.80. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This firm-fixed-price delivery order, valued at $11,032.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, by June 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a ceiling value of $8,714.52 and a completion date of June 6, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,600.96, is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has a firm fixed-price pricing type and an ultimate completion date of March 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract, valued at $12,095.55, is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product. The contract has a performance period through September 30, 2024 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical products and supplies to support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,752.48 award is for the delivery of "ABRYSVO VIAL WITH DILUENTS", a medical product, with a period of performance through March 13, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA, which has a potential...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has a firm fixed price of $8,063.70 and a completion date of October 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,684.99 firm-fixed-price contract is for the provision of ABRYSVO VIAL WITH DILUENTS, a medical product. The contract has an ultimate completion date of January 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ABRYSVO VIAL WITH DILUENT SYRGS. The contract has a ceiling value of $2,018.02 and a completion date of June 26, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...